Vitamin D insufficiency predicts time to first treatment (TFT) in early chronic lymphocytic leukemia (CLL)

Leukemia Research

Volumn 36, Issue 4, 2012, Pages 443-447

  Molica, Stefano ^a   Digiesi, Giovanna ^b   Antenucci, Anna ^b   Levato, Luciano ^a   Mirabelli, Rosanna ^a   Molica, Matteo ^a   Gentile, Massimo ^c   Giannarelli, Diana ^b   Sperduti, Isabella ^b   Morabito, Fortunato ^c   Conti, Laura ^b  

^a Azienda Ospedaliera di Catanzaro   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^c Azienda Ospedaliera Annunziata di Cosenza   (Italy)

Author keywords

Clinical outcome; CLL; Prognostic variables; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; BETA 2 MICROGLOBULIN; CD38 ANTIGEN; HEMOGLOBIN; IMMUNOGLOBULIN HEAVY CHAIN; LACTATE DEHYDROGENASE; PROTEIN KINASE ZAP 70; THYMIDINE KINASE;

ADULT; AGE; AGED; ARTICLE; AUTUMN; CANCER STAGING; CHEMOLUMINESCENCE; CHRONIC LYMPHATIC LEUKEMIA; COHORT ANALYSIS; COMPETITIVE CHEMILUMINESCENCE IMMUNOASSAY; DISEASE ASSOCIATION; DISEASE SEVERITY; EARLY CANCER; ENZYME BLOOD LEVEL; FEMALE; GENDER; GENE MUTATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMMUNOASSAY; IMMUNOGLOBULIN GENE; IMMUNOGLOBULIN VARIABLE REGION; LYMPHOCYTE COUNT; LYMPHOCYTOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; PERIPHERAL LYMPHOCYTE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SPRING; SUMMER; THROMBOCYTE COUNT; TIME TO FIRST TREATMENT; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; WINTER;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84857238836     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2011.10.004     Document Type: Article

References (27)

1. Holick M.F. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 2006, 81:353-373.
2. Chen P., Hu P., Xie D., Qin Y., Wang F., Wang H. Meta-analysis of vitamin D, calcium and the prevention of breast cancer. Breast Cancer Res Treat 2010, 121(2):469-477.
3. Gandini S., Boniol M., Haukka J., et al. Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer 2011, 128(6):1414-1424.
4. Helzlsouer K.J., VDPP Steering Committee Overview of the cohort consortium vitamin D pooling project of rarer cancers. Am J Epidemiol 2010, 172(1):4-9.
5. Giovannucci E., Liu Y., Rimm E.B., et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 2006, 98(7):451-459.
6. Lim U., Freedman D.M., Hollis B.W., et al. A prospective investigation of serum 25-hydroxyvitamin D and risk of lymphoid cancers. Int J Cancer 2009, 124(4):979-986.
7. Drake M.T., Maurer M.J., Link B.K., et al. Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma. J Clin Oncol 2010, 28(27):4191-4198.
8. Purdue M.P., Freedman D.M., Gapstur S.M., et al. Circulating 25-hydroxyvitamin D and risk of non-Hodgkin lymphoma: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol 2010, 172(1):58-69.
9. Shanafelt T.D., Drake M.T., Maurer M.J., et al. Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia. Blood 2011, 117(5):1492-1498.
10. Cheson B.D., Bennett J.M., Grever M., et al. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 1996, 87(12):4990-4997.
11. Hallek M., Cheson B.D., Catovsky D., et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 2008, 111(12):5446-5456.
12. Ersfeld D.L., Rao D.S., Body J.J., et al. Analytical and clinical validation of the 25 OH vitamin D assay for the LIAISON automated analyzer. Clin Biochem 2004, 37(October (10)):867-874.
13. Holick M.F. Vitamin D deficiency. N Engl J Med 2007, 357(3):266-281.
14. Molica S., Digiesi G., Battaglia C., et al. BAFF serum level predicts time to first treatment in early chronic lymphocytic leukemia. Eur J Haematol 2010, 85(4):314-320.
15. Dohner H., Stilgenbauer S., Benner A., et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000, 343:1910-1916.
16. Ginde A.A., Liu M.C., Camargo C.A. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med 2009, 169:626-632.
17. Rosenwald A., Alizadeh A.A., Widhopf G., et al. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 2001, 194(11):1639-1647.
18. Pepper C., Thomas A., Hoy T., et al. The vitamin D3 analog EB1089 induces apoptosis via a p53-independent mechanism involving p38 MAP kinase activation and suppression of ERK activity in B-cell chronic lymphocytic leukemia cells in vitro. Blood 2003, 101(7):2454-2460.
19. Petrini M., Galbraith R.M., Werner P.A., Emerson D.L., Arnaud P. Gc (vitamin D binding protein) binds to cytoplasm of all human lymphocytes and is expressed on B-cell membranes. Clin Immunol Immunopathol 1984, 31(2):282-295.
20. Constans J., Oksman F., Viau M. Binding of the apo and holo forms of the serum vitamin D-binding protein to human lymphocyte cytoplasm and membrane by indirect immunofluorescence. Immunol Lett 1981, 3(3):159-162.
21. Hollis B.W. The determination of circulating 25-hydroxyvitamin D: no easy task. J Clin Endocrinol Metab 2004, 89(7):3149-3151.
22. Lai J.K.C., Lucas R.M., Banks E., et al. Variability in vitamin D assays impairs clinical assessment of vitamin D status. Intern Med J 2011, (March). [Epub ahead of print]. 10.1111/j.1445-5994.2011.02471.x.
23. Pepper C., Fegan C. CLL: a supplementary question?. Blood 2011, 117(5):1439-1440.
24. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med 1994, 330(15):1029-1035.
25. Omenn G.S., Goodman G., Thornquist M., et al. The beta-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers. Cancer Res 1994, 54(7 Suppl.). 2038s-2043s.
26. Raina V., Cunningham D., Gilchrist N., Soukop M. Alfacalcidol is a nontoxic, effective treatment of follicular small-cleaved cell lymphoma. Br J Cancer 1991, 63(3):463-465.
27. CLL Trialists' CollaborativeGroup Chemotherapeutic options in chronic lymphocytic leukemia: a meta-analysis of the randomized trials. J Natl Cancer Inst 1999, 91(10):861-868.